Sign in Create account
Sign in and upgrade to a paid plan to export financials as CSV.

Unjha Formulations Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 531762
₹32.50
▲ 0.50 (1.56%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
57/100
Moderate
Valuation
30/100
Fairly Valued
Momentum
52/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹15 Cr
PE (TTM)
31.0
Industry median 36.1 (152 companies)
Price to Book
3.8
PEG (TTM)
-0.5
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
7.9
Free Cash Flow
₹1 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
-61.11%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
-60.73%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
1.12%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
-59.74%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
-8.47%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
11.83
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
102.55
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
4.75%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
4.78%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
4.77%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
12.79%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
18.66%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
18.34%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

4 of 7 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • Yes Return on equity is 15% or more (18.3%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • Yes 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Sell Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
1.6%
Low 31.0000 · High 32.5000
1W return
1.6%
Low 30.5000 · High 33.2500
1M return
18.5%
Low 27.5000 · High 36.3800
52W return
7.9%
Low 23.8500 · High 36.3800
Lifetime High ₹35.4500 (Sept. 9, 2026)
Lifetime Low ₹1.5300 (April 15, 2009)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish6
Bearish0
5D
32.1
10D
32.0
20D
31.4
50D
29.3
100D
26.8
200D
22.3

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

32.00
Pivot
First resistance33.00
Second resistance33.50
Third resistance34.50
First support31.50
Second support30.50
Third support30.00
Day RSI56.9
Day MFI31.1
Day MACD1.03
Day MACD signal1.30

Beta

1M0.80
3M1.44
1Y1.44
3Y0.14

Price change analysis

↑ 18.5%
Over 1 Month
LowHigh
27.5036.38
↑ 7.9%
Over 3 Months
LowHigh
23.8536.38
↑ 7.9%
Over 6 Months
LowHigh
23.8536.38
↑ 7.9%
Over 1 Year
LowHigh
23.8536.38
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 31.0 (own history: 8.0–31.9)
Sell Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹3 Cr
Net profit (June 30, 2026)
₹0 Cr
Basic EPS (June 30, 2026)
₹0.3500

Ranks #171 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter36.92%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 36.92% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 37 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
4 Nov 2024 USHA JAWAHARLAL KALRO Bulk Sell 33,354 34.9900 BSE
4 Nov 2024 USHA JAWAHARLAL KALRO Bulk Buy 33,354 33.8000 BSE
7 Aug 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Buy 20,161 28.3200 BSE
7 Aug 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Sell 25,515 28.3200 BSE
6 Feb 2024 SATYA PRAKASH MITTAL HUF Bulk Buy 27,333 22.5200 BSE
13 Dec 2022 PRADEEP KUMAR JAIN Bulk Sell 59,535 12.6000 BSE
6 Jul 2021 BHARAT HASTIMAL JAIN HUF Bulk Sell 1,772 11.8700 BSE
6 Jul 2021 PURSHOTTAM AGARWAL Bulk Sell 37,612 11.5000 BSE
6 Jul 2021 BHARAT HASTIMAL JAIN HUF Bulk Buy 39,492 11.4900 BSE
21 Jun 2021 PURSHOTTAM AGARWAL Bulk Sell 23,000 11.2000 BSE

All bulk and block deals →

Corporate Announcements

All 2 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
8 Sep 2026 Company Update Unjha Formulations Ltd - 531762 - Submissions Of XML File For Financial Statement I.E. Balance Sheet , P&L Accounts And Cash Flow Statement As On 31.03.2026 (AGM Held On 14/08/2026) As Per SEBI (Listing Obligation And Disclosure Requirements) Regulations,2015
8 Sep 2026 Company Update Unjha Formulations Ltd - 531762 - Submissions Of XML File For Financial Statement I.E. Balance Sheet , P&L Accounts And Cash Flow Statement As On 31.03.2026 (AGM Held On 14/08/2026) As Per SEBI (Listing Obligation And Disclosure Requirements) Regulations,2015

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (102.5x)

Weaknesses

  • Thin net profit margin (4.7%)
  • Declining revenue YoY (-8.5%)
  • Declining profit YoY (-59.7%)

Opportunities

Data unavailable.

Threats

Data unavailable.

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Unjha Formulations Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.